-
Something wrong with this record ?
Reduced sulfotransferase SULT2A1 activity in patients with Alzheimer's disease
M. Vaňková, M. Hill, M. Velíková, J. Včelák, G. Vacínová, P. Lukášová, D. Vejražková, K. Dvořáková, R. Rusina, I. Holmerová, E. Jarolímová, H. Vaňková, B. Bendlová
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13543
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Enzyme Activation physiology MeSH
- Alzheimer Disease blood diagnosis MeSH
- Biomarkers blood MeSH
- Humans MeSH
- Aged MeSH
- Sulfotransferases blood MeSH
- Zona Reticularis metabolism MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Steroids are important components in the pathophysiology of Alzheimer's disease (AD). Although their role has been studied, the corresponding metabolomic data is limited. In the present study we evaluate the role of steroid sulfotransferase SULT2A1 in the pathophysiology of AD on the basis of circulating steroids (measured by GC-MS), in which the sulfation catalyzed by SULT2A1 dominates over glucuronidation (pregnenolone/sulfate, DHEA/sulfate, androstenediol/sulfate and 5alpha-reduced pregnane and androstane catabolites). To estimate a general trend of SUL2A1 activity in AD patients we compared the ratios of steroid conjugates to their unconjugated counterparts (C/U) in controls (11 men and 22 women) and AD patients (18 men and 16 women) for individual circulating steroids after adjustment for age and BMI using ANCOVA model including the factors AD status and gender. Decreased C/U ratio for the C19 steroids demonstrate an association between attenuated sulfation of C19 steroids in adrenal zona reticularis and the pathophysiology of AD.
3rd Faculty of Medicine Charles University Prague Czech Republic
Faculty of Humanities Charles University Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16031131
- 003
- CZ-PrNML
- 005
- 20190819085802.0
- 007
- ta
- 008
- 161101s2015 xr f 000 0|ENG||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933160 $2 doi
- 035 __
- $a (PubMed)26680489
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a ENG
- 044 __
- $a xr
- 100 1_
- $a Vaňková, Markéta, $u Institute of Endocrinology, Prague, Czech Republic $d 1974- $7 xx0140642
- 245 10
- $a Reduced sulfotransferase SULT2A1 activity in patients with Alzheimer's disease / $c M. Vaňková, M. Hill, M. Velíková, J. Včelák, G. Vacínová, P. Lukášová, D. Vejražková, K. Dvořáková, R. Rusina, I. Holmerová, E. Jarolímová, H. Vaňková, B. Bendlová
- 520 9_
- $a Steroids are important components in the pathophysiology of Alzheimer's disease (AD). Although their role has been studied, the corresponding metabolomic data is limited. In the present study we evaluate the role of steroid sulfotransferase SULT2A1 in the pathophysiology of AD on the basis of circulating steroids (measured by GC-MS), in which the sulfation catalyzed by SULT2A1 dominates over glucuronidation (pregnenolone/sulfate, DHEA/sulfate, androstenediol/sulfate and 5alpha-reduced pregnane and androstane catabolites). To estimate a general trend of SUL2A1 activity in AD patients we compared the ratios of steroid conjugates to their unconjugated counterparts (C/U) in controls (11 men and 22 women) and AD patients (18 men and 16 women) for individual circulating steroids after adjustment for age and BMI using ANCOVA model including the factors AD status and gender. Decreased C/U ratio for the C19 steroids demonstrate an association between attenuated sulfation of C19 steroids in adrenal zona reticularis and the pathophysiology of AD.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a Alzheimerova nemoc $x krev $x diagnóza $7 D000544
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a aktivace enzymů $x fyziologie $7 D004789
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a sulfotransferasy $x krev $7 D015238
- 650 _2
- $a zona reticularis $x metabolismus $7 D015385
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hill, Martin, $d 1962- $7 mzk2005304431 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Velíková, Marta $7 xx0209755 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Včelák, Josef, $d 1971- $7 xx0107261 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Vacínová, Gabriela $7 xx0228532 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Lukášová, Petra $7 xx0078664 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Vejražková, Daniela $7 xx0131980 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Dvořáková, Kateřina $7 xx0070717 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Rusina, Robert, $d 1969- $7 mzk2007386024 $u Thomayer Hospital, Prague, Czech Republic; Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, First Faculty of Medicine and General University Hospital in Prague, Czech Republic
- 700 1_
- $a Holmerová, Iva, $d 1955- $7 mzk2004246561 $u Faculty of Humanities, Charles University, Prague, Czech Republic
- 700 1_
- $a Jarolímová, Eva $7 mzk2007417178 $u Faculty of Humanities, Charles University, Prague, Czech Republic
- 700 1_
- $a Vaňková, Hana, $d 1978- $7 xx0104561 $u Faculty of Humanities, Charles University, Prague, Czech Republic; Third Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Bendlová, Běla, $d 1962- $7 jo20000074069 $u Institute of Endocrinology, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 64, Suppl 2 (2015), s. S265-S273
- 773 0_
- $t Luboslav Stárka - doyen of the Czech endocrinology $g (2015), s. S265-S273 $w MED00191409
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20161101 $b ABA008
- 991 __
- $a 20190819090036 $b ABA008
- 999 __
- $a ok $b bmc $g 1172705 $s 955789
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 64 $c Suppl 2 $d S265-S273 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC ##
- $a 2015 $d S265-S273 $m Luboslav Stárka - doyen of the Czech endocrinology $x MED00191409
- GRA __
- $a NT13543 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20161101